Average Co-Inventor Count = 10.83
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Vertex Pharmaceuticals, Inc. (13 from 1,147 patents)
2. Smithkline Beecham Corporation (2 from 2,198 patents)
3. Novartis Vaccines & Diagnostics, Gmbh (1 from 245 patents)
4. Glaxosmithkline Intellectual Property Development Limited (1 from 230 patents)
5. Glaxo Inc. (1 from 56 patents)
6. Astex Therapeutics Limited (123 patents)
18 patents:
1. 12441703 - Carboxamides as modulators of sodium channels
2. 12440481 - Esters and carbamates as modulators of sodium channels
3. 12331057 - Modulators of alpha-1 antitrypsin
4. 12281057 - Carboxamides as modulators of sodium channels
5. 12258333 - N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channels
6. 12247021 - Substituted tetrahydrofurans as modulators of sodium channels
7. 11919887 - Substituted tetrahydrofurans as modulators of sodium channels
8. 11884672 - Modulators of alpha-1 antitrypsin
9. 11834441 - Substituted tetrahydrofurans as modulators of sodium channels
10. 11827627 - N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channels
11. 11623924 - Modulators of alpha-1 antitrypsin
12. 11603351 - Carboxamides as modulators of sodium channels
13. 11053234 - 1,3 di-substituted cyclobutane or azetidine derivatives as hematopoietic prostaglandin D synthase inhibitors
14. 10647661 - Carboxamides as modulators of sodium channels
15. 7625909 - Substituted quinazolinone compounds